North Tide Capital’s Quest Diagnostics DGX Stock Holding History

North Tide Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-500,000	Closed	-$36.3M	–	18
2015 Q2	$36.3M	Buy	+500,000	New	+$36.9M	2.62%	13
2015 Q1	–	Sell	-1,000,000	Closed	-$67.1M	–	23
2014 Q4	$67.1M	Buy	1,000,000 +500,000	+100%	+$31.6M	4.51%	8
2014 Q3	$30.3M	Sell	500,000 -500,000	-50%	-$30.8M	2.31%	17
2014 Q2	$58.7M	Hold	1,000,000	–	–	4.11%	11
2014 Q1	$57.9M	Hold	1,000,000	–	–	4.88%	8
2013 Q4	$53.5M	Buy	1,000,000 +300,000	+43%	+$17.8M	4.69%	8
2013 Q3	$43.3M	Buy	+700,000	New	+$41.9M	4.54%	9

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

North Tide Capital's DGX Position: Q3 2015 in Review

North Tide Capital sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 500,000 shares — an estimated $36.3M sold.

North Tide Capital first reported a position in DGX in Q3 2013 and held it in 7 quarters. The position peaked at $67.1M in Q4 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

North Tide Capital reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
North Tide Capital sold 500,000 Quest Diagnostics shares in Q3 2015, an estimated $36.3M.
North Tide Capital first reported a position in Quest Diagnostics in Q3 2013 and held it in 7 quarters.
North Tide Capital's Quest Diagnostics position peaked at $67.1M in Q4 2014.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on North Tide Capital's 13F filing for Q3 2015, filed 16 Nov 2015.